' Quad Shot' RT, Immunotherapy Improves Local Control in HNC'Quad Shot' RT, Immunotherapy Improves Local Control in HNC
A palliative Quad Shot radiotherapy regimen alongside concurrent immunotherapy can improve local control in symptomatic patients with head and neck cancer but may not improve overall survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Some Cancer Patients Can Find It Hard to Tell Family and Friends
(MedPage Today) -- Ever since Anthony Bridges found out he had prostate cancer 6 years ago, he hasn't stopped talking about it. He told his Facebook friends immediately.
Now, the 68-year-old man from Georgia spends time working with others to... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 31, 2024 Category: Hematology Source Type: news
The Cancer Journey Is Not Unique to the Royals
(MedPage Today) -- The royal family in the U.K. has had a rough start to 2024. The culprit is cancer.
In January, news broke that Sarah Ferguson, the Duchess of York, had been diagnosed with malignant skin cancer during her breast cancer treatment... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 30, 2024 Category: Hematology Source Type: news
Active Surveillance Doesn't Increase Malpractice Risk Active Surveillance Doesn't Increase Malpractice Risk
Physicians should feel reassured in recommending active surveillance as a management strategy for low-risk cancers, as no successful malpractice cases related to this approach have been found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations
(MedPage Today) -- An author shares his own story about the "pay me now or pay me later" relationship between cancer chemotherapy and heart disease. (Washington Post)
Three pending cases before the U.S. Supreme Court have the potential to reshape... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 29, 2024 Category: Hematology Source Type: news
PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma
(MedPage Today) -- An investigational PD-1 inhibitor combined with chemotherapy showed impressive activity in treatment-naive patients with advanced extranodal natural killer/T-cell lymphoma (ENKTL), according to results from a small Chinese single... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 28, 2024 Category: Hematology Source Type: news
Longer Exclusive Breastfeeding May Lower Risk for Childhood Hematologic Cancers
THURSDAY, March 28, 2024 -- Exclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study published online March 26 in JAMA Network Open.Signe Holst S øegaard, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 28, 2024 Category: Pharmaceuticals Source Type: news
Ovarian Cancer Red Flags: What to Know to Quicken Diagnoses Ovarian Cancer Red Flags: What to Know to Quicken Diagnoses
Although ovarian cancer can be treated successfully if caught early, two-third women with the disease are diagnosed later in its course, when the illness is much more difficult to treat.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2024 Category: Cancer & Oncology Tags: Ob/Gyn & Women ' s Health Source Type: news
Once-Rejected Drug Now FDA Approved for CKD-Related Anemia
(MedPage Today) -- The FDA approved vadadustat (Vafseo) for chronic kidney disease (CKD)-related anemia in adults who have been on dialysis for at least 3 months, developer Akebia Therapeutics announced on Wednesday.
"Patients receiving maintenance... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 28, 2024 Category: Hematology Source Type: news
ASCO Releases Vaccination Guidelines for Adults With Cancer ASCO Releases Vaccination Guidelines for Adults With Cancer
A recent ASCO guideline provides recommendations for routine and additional vaccinations for adults with solid tumors or hematologic malignancies as well as their household contacts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Can Minimally Invasive Surgery Match Open in Ovarian Cancer? Can Minimally Invasive Surgery Match Open in Ovarian Cancer?
Minimally invasive surgery for ovarian cancer does not appear to affect survival compared with open surgery when tumors are completely removed.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
French Cohort Shows Good Prognosis of MSI Colorectal Cancer French Cohort Shows Good Prognosis of MSI Colorectal Cancer
Nonmetastatic microsatellite instability colorectal cancers nevertheless entailed a high risk for recurrence in stage III, especially when not treated with adjuvant chemotherapy.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 28, 2024 Category: Pathology Tags: Hematology-Oncology Source Type: news
Amivantamab Offers Post-Progression Benefit in EGFRm NSCLC Amivantamab Offers Post-Progression Benefit in EGFRm NSCLC
Even if patients with EGFR-mutated lung cancer progress on amivantamab plus chemotherapy, there is a survival benefit over chemotherapy alone, follow-up analyses of PAPILLON and MARIPOSA-2 showed.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 28, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Lung Cancer Screening Unveils Hidden Health Risks Lung Cancer Screening Unveils Hidden Health Risks
Screening for lung cancer can identify more than lung malignancies.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 28, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
'Excellent' Outcomes After Complete Response in Lymph Node-Positive Breast Cancer
(MedPage Today) -- Patients with early lymph node-positive breast cancer and pathologic complete response (pCR) after neoadjuvant therapy had similar long-term recurrence rates and survival regardless of the type of adjuvant therapy they received... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 27, 2024 Category: Hematology Source Type: news
